Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: Influence of methimazole treatment

Cell Biochemistry and Function

Volumn 14, Issue 2, 1996, Pages 97-104

  Werner, M C ^a,b   Costa Rosa, L F B P ^b   Romaldini, J H ^a   Curi, R ^b  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Glucose; Glutamine; Graves' disease; Immune function; Lymphocytes; Methimazole; Thyroid hormones

Indexed keywords

CARBON 14; CARBON DIOXIDE; CITRATE SYNTHASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMINASE; GLUTAMINE; HEXOKINASE; LIOTHYRONINE; THIAMAZOLE; THYROXINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GRAVES DISEASE; HUMAN; HUMAN CELL; HYPERTHYROIDISM; LYMPHOCYTE; MALE; PATIENT; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; CARBON DIOXIDE; CARBON RADIOISOTOPES; CELLS, CULTURED; CITRATE (SI)-SYNTHASE; CULTURE MEDIA; FEMALE; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTAMINASE; GLUTAMINE; GRAVES DISEASE; HEXOKINASE; HUMANS; LYMPHOCYTES; MALE; METHIMAZOLE; MIDDLE AGED; THYROID FUNCTION TESTS; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

EID: 0029890128     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.654     Document Type: Article

References (43)

1. Wartofsky, L. (1993). Has the use of antithyroid drugs for Graves' disease become obsolete? Thyroid, 3, 335-344.
2. Romaldini, J. H., Bomberg, N., Werner, R. S., Tanaka, L. M., Rodrigues, H. F., Werner, M. C., Farah, C. F. and Reis, L. C. F. (1993). Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Grave's hyperthyroidism. J. Clin Endocrinol. Metab., 57, 563-570.
3. Hazhizume, K., Ichikawa, K., Sakurai, A., Suzuki, S., Takeda, T., Kobayashi, M., Miyamoto, T., Arai, M. and Nagasawa, T. (1992). Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N. Engl. J. Med., 324, 947-953.
4. Ohashi, H., Okugawa, T. and Itoh, M. (1991). Circulating activated T cell subsets in atuoimnrane thyroid disease: differences between untreated and treated patients. Acta Endocrinol, 125, 502-509.
5. Hoermann, R., Schum-Dreger, P. M. and Mann, K. (1993). Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockage of the thyrotropin receptor. Thyroid, 3, 273-278.
6. Zakarija, M., McKenzie, J. M. and Banovac, K. (1980). The clinical significance of assay of thyroid-stimulating antibody in Graves' disease. Ann. Int. Med., 93, 28-32.
7. Codaccioni, J. L., Orgiazzi, J., Blanc, P., Pugeat, M., Roulier, R. and Carayon, P. (1988). Lasting remission in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease. J. Clin Endocrinol. Metab., 67, 656-662.
8. McGregor, A.M., Petersen, M. M., McLachlan, S. M., Rooke, P., Smith, B. R. and Hall, R. (1980). Carbmazole and the autoimmune response in Graves' disease. N. Engl. J. Med., 303, 302-307.
9. Saji, M., Moriarty, J., Ban, T., Singer, D. S. and Kohn, L. D. (1992). Major histocorapatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole and iodide as well as interferon, J. Clin. Endocrinol. Metab., 75, 871-878.
10. Bodolay, E., Suranyi, P., Juhasz, F., Stenszky, V., Balazs, C. and Farid, N. R. (1988). Methimazole blocks Graves' IgG but not interferon-γ HLA-DR expression by thyroid cells. Immunol. Lett., 18, 167-172.
11. Volpe, R. (1993). Suppressor T lymphocyte dysfunction is important in the pathogenesis of autoimmune thyroid disease: a perspective. Thyroid, 3, 345-352.
12. Weiss, I. and Davies, T. F. (1981). Inhibition of immunogiobulin-secretion cells by antithyroid drugs. J. Clin. Endocrinol. Metab., 53, 1223-1228.
13. McLachan, S. M., Pegg, C. A. S., Atherton, M. C., et al. (1985). The effect of carbimazole on thyroid autoantibody synthesis by thyroid lymphocytes. J. Clin. Endocrinol. Metab., 60, 1237-1242.
14. Singer, D. S., Kohn, K. D., Zinger, H. and Mozes, E. (1994). Methimazole prevents induction of experimental systemic lypus erythematosus in mice. J. Immunol., 153, 873-880.
15. Weetman, A. P., Holt, M. E., Campbell, A. K., Hall, R. and McGregor, A. M. (1984). Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br. Med. J., 288, 518-520.
16. Weetman, A. P., McGregor, A. M. and Hall, R. (1983). Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin. Immunol. Immuno-pathol., 28,39-45.
17. Ardawi, M. S. M. and Newsholme, E. A. (1982). Maximum activities of some enxymes of glycolysis, the tricarboxylic acid cycle and glutamine utilization pathways in lymphocytes of the rat. Biochem. J., 208, 743-748.
18. Ardawi, M. S. M. and Newsholme, E. A. (1983). Giutamine metabolism in lymphocytes of the rat. Biochem. J., 212, 835-842.
19. Serrano, M. A. R., Curi, R., Parry-Billings, M., Williams, J. F. & Newsholme, E. A. (1993). Effects of glucocorticoids on lymphocytes metabolism. Am. J. Physiol, 264, E24-E28.
20. Newsholme, P., Curi, R., Gordon, S. and Newsholme, E. A. (1986). Metabolism of glucose, giutamine, long chain fatty acids and ketone bodies by murine macrophages. Biochem. J., 239, 121-125.
21. Newsholme, E. A., Newsholme, P., Curi, R., Challoner, M. A. and Ardawi, M. S. M. (1988). A role for muscle in the immune system and its importance in surgery, trauma, sepsis and burns. Nutrition, 4, 261-268.
22. Parry-Billings, M., Baigrie, R. J., Lament, P. M., Morris, P. J. and Newsholme, E. A. (1992). Effects of major and minor surgery on plasma giutamine and cytokine levels. Arch. Surg., 127, 1237-1240.
23. Holm, A-C., Lemarchand-Béraud, T., Scazziga, B-R. and Cuttelod, S. (1975). Human lymphocyte binding and deiodination of thyroid hormones in relation to thyroid function. Acta Endocrinol., 80, 642-656.
24. Liewendahl, K., Rosengärd, S. and Lamberg, B-A. (1978). Nuclear binding of triiodothyronine and thyroxine in lymphocytes from subjects with hyperthyroidism, hypothyroidism and resistance to thyroid hormones. Clin. Chim. Acta, 83, 41-48.
25. Ruf, J., Czamocka, B., Ferrand, M., Doullouis, F. and Carayon, P. (1988). Novel routine assay of thyroperoxidase autoantibodies. Clin. Chem., 34, 2231-2234.
26. Costa Rosa, L. F. B. P., Almeida, A. F., Safi, D. A. and Curi, R. (1993). Metabolic and functional changes in lymphocytes and macrophages as induced by ageing. Physiol. Behav., 53, 651-656.
27. Abou-Rabia, N. and Kendall, M. D. (1994). Involution of the rat thymus in experimentally induced hypothyroidism. Cell Tissue Res., 277, 447-455.
28. Bachman, S. E. and Mashaly, M. M. (1987). Relationship between circulating thyroid hormones and cell-mediated immunity in immature male chickens. Dev. Comp. Immunol., 11, 203-213.
29. Paavonen, T. (1982). Enhancement of human B lymphocyte differentiation in vitro by thyroid hormone. Scand. J. Immunol., 15, 211-215.
30. Provinciali, M., Muzzioli, M., DiStefano, G. and Fabris, N. (1991). Recovery of spleen cell natural killer activity by thyroid hormone treatment in old mice. Nat. Immun. Cell Growth Regul., 10, 226-236.
31. Lin, H-Y., Thacore, H. R., Davis, P. J. and Davis, F. B. (1994). Thyroid hormone potentiates the antiviral action of interferon-γ in cultured human cells. J. Clin. Endocrinol. Metab., 79, 62-65.
32. Mooij, P., Simons, P. J., de Haan-Meulman, M., de Wit, H. J. and Drexhage, H. A. (1994). Effect of thyroid hormones and other iodinated compounds on the transition of monocyte into veiled/dendritic cells: role of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor a and interleukin-6. J. Endocrinol., 140, 503-512.
33. Balàzs, C., Leovey, A., Szabo, M. and Bako, G. (1980). Stimulating effect of triiodothyronine on cell-mediated immunity. Eur. J. Clin. Pharmacol., 17, 19-23.
34. Chatterjee, S. and Chandel, A. (1983). Immunomodulatory role of thyroid hormones: in vivo effect of thyroid hormones on the blastogenic responses of lymphoid tissues. Acta Endocrinol., 103, 95-100.
35. Costa Rosa, L. F. B. P., Safi, D. A. and Curi, R. (1995). Effect of hypo- and hyperthyroidism on the function and metabolism of macrophages in rats. Cell Biochem. Funct., 13, 141-147.
36. Chabaud, O. and Lissitsky, S. (1977). Thyrotropin specific binding to human peripheral blood monocytes and polymorphonuclear leukocytes. Mol. Cell. Endocrinol., 7, 79-86.
37. Blalock, J. E., Johnson, H. M., Smith, E. M. and Torres, B. A. (1985). Enhancement of the in vitro antibody response by thyrotropin. Biochem. Biophys. Res. Comm., 125, 30-35.
38. Kruger, T. E. and Blalock, J. E. (1986). Cellular requirements for thyrotropin enhancement of in vitro antibody production. J. Immunol., 1, 197-199.
39. Almeida, A. F., Curi, R., Newsholme, P. and Newsholme, E. A. (1989). Maximal activities of key enzymes of glutaminolysis, glycolysis, Krebs cycle and pentose-phosphate pathways of several tissues in mature and aged rats. Int. J. Biochem., 21, 937-940.
40. Weetman, A. P. (1992). How antithyroid drugs work in Graves' disease, Clin. Endocrinol., 37, 317-318.
41. 35S]-methimazole by human and rat lymphocytes. Acta Endocrinol., 102, 68-70.
42. 35S]methimazole by monocytes and macrophages. Acta Endorcinol., 107, 366-370.
43. Weetman, A. P. (1992). The role of T lymphocytes in thyroidassociated ophthalmopathy. Autounmunity, 13, 69-73.